1-3 of 3
Victor Hugo Jimenez-Zepeda, MD
Close
Sort by
Journal Articles

Absolute Lymphocyte Count At Day+15 and +30 Post-ASCT As Predictors of Early and 1-Year Mortality for Patients with AL Amyloidosis Treated with a Single Autologous Stem Cell Transplant

Victor Hugo Jimenez-Zepeda, MD PD, Donna Reece, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Vishal Kukreti, MD
Journal: Blood
Blood (2012) 120 (21): 4518.
https://doi.org/10.1182/blood.V120.21.4518.4518
Published: 2012
Journal Articles

BP-2-047, a Novel Small-Molecule Inhibitor of Stat3 Is Active in Myeloma Pre-Clinical Models: Rationale for Treatment of Stat3-Dependent Multiple Myeloma

Victor Hugo Jimenez-Zepeda, MD, Brent DG Page, BS, Li Zhia Hua, Ellen Wei, Leif Bergsagel, M.D., Patrick T Gunning, PhD, Suzanne Trudel, MD, MSC, FRCPC
Journal: Blood
Blood (2012) 120 (21): 576.
https://doi.org/10.1182/blood.V120.21.576.576
Published: 2012
Journal Articles

Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

Victor Hugo Jimenez-Zepeda, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Rodger E. Tiedemann, MD, PhD FRACP FRCPA, Vishal Kukreti, MD
Journal: Blood
Blood (2012) 120 (21): 595.
https://doi.org/10.1182/blood.V120.21.595.595
Published: 2012